Immunochemotherapy with interleukin-2, interferon- α and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study

In patients with metastatic renal cell carcinoma response rates of 7–26% have been achieved with immunotherapy. A high response rate of 48% in 35 patients has been reported for treatment with the combination of interferon-α (IFN-α), interleukin-2 (IL-2) and 5-fluorouracil (5-FU) (Atzpodien et al (19...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Herpen, C M L van, Jansen, R L H, Kruit, W H J, Hoekman, K, Groenewegen, G, Osanto, S, Mulder, P H M De
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2000
Témata:
Regular Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374413/
https://ncbi.nlm.nih.gov/pubmed/10732744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.1999.0997
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky